Abstract
References
Articles referenced by this article (49)
Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9.
J Biol Chem, (39):36337-36343 2001
MED: 11470789
Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.
EMBO J, (7):1774-1784 2001
MED: 11285240
TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing.
J Biol Chem, (43):28852-28859 2008
MED: 18703504
Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene.
Nucleic Acids Res, (18):6000-6010 2005
MED: 16254078
TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes.
Proc Natl Acad Sci U S A, (9):3347-3352 2012
MED: 22323604
TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression.
Proc Natl Acad Sci U S A, (10):3785-3789 2008
MED: 18305152
Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6.
EMBO J, (1):209-221 2009
MED: 19910924
TDP-43 regulates Drosophila neuromuscular junctions growth by modulating Futsch/MAP1B levels and synaptic microtubules organization.
PLoS One, (3):e17808 2011
MED: 21412434
Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection.
Genes Dev, (15):1679-1684 2012
MED: 22855830
TDP-43 regulates its mRNA levels through a negative feedback loop.
EMBO J, (2):277-288 2010
MED: 21131904
Show 10 more references (10 of 49)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Article citations
Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies.
Pharmaceuticals (Basel), 17(10):1391, 18 Oct 2024
Cited by: 0 articles | PMID: 39459030 | PMCID: PMC11510162
Review Free full text in Europe PMC
Conformational Enigma of TDP-43 Misfolding in Neurodegenerative Disorders.
ACS Omega, 9(39):40286-40297, 20 Sep 2024
Cited by: 0 articles | PMID: 39372031 | PMCID: PMC11447851
Review Free full text in Europe PMC
Molecular Mechanisms of Phase Separation and Amyloidosis of ALS/FTD-linked FUS and TDP-43.
Aging Dis, 15(5):2084-2112, 01 Oct 2024
Cited by: 8 articles | PMID: 38029395 | PMCID: PMC11346406
Review Free full text in Europe PMC
Creation of de novo cryptic splicing for ALS and FTD precision medicine.
Science, 386(6717):61-69, 03 Oct 2024
Cited by: 1 article | PMID: 39361759 | PMCID: PMC7616720
Multivalent Protein-Nucleic Acid Interactions Probed by Composition-Gradient Multiangle Light Scattering.
ACS Omega, 9(39):41003-41010, 21 Sep 2024
Cited by: 0 articles | PMID: 39371993 | PMCID: PMC11447847
Go to all (201) article citations
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9.
J Biol Chem, 276(39):36337-36343, 24 Jul 2001
Cited by: 448 articles | PMID: 11470789
TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing.
J Biol Chem, 280(45):37572-37584, 12 Sep 2005
Cited by: 317 articles | PMID: 16157593
CELF proteins regulate CFTR pre-mRNA splicing: essential role of the divergent domain of ETR-3.
Nucleic Acids Res, 38(20):7273-7285, 14 Jul 2010
Cited by: 20 articles | PMID: 20631008 | PMCID: PMC2978352
Structural insights into TDP-43 in nucleic-acid binding and domain interactions.
Nucleic Acids Res, 37(6):1799-1808, 27 Jan 2009
Cited by: 191 articles | PMID: 19174564 | PMCID: PMC2665213
Funding
Funders who supported this work.
Medical Research Council (1)
Post transcriptional regulatory networks
Prof Jernej Ule, MRC Laboratory of Molecular Biology
Grant ID: MC_U105185858
Wellcome Trust (1)
RNA processing proteins and neurodegeneration: exploring mechanisms and modelling disease.
Professor Christopher Shaw, King's College London
Grant ID: 089701